Insights into the pathogenesis of Paget's disease

Annals of the New York Academy of Sciences

Volumn 1192, Issue , 2010, Pages 176-180

  Roodman, G David ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Measles virus; Paget's disease; Sequestosome 1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; PROTEIN P62; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR ALPHA;

AUTOPHAGY; BONE MARROW; CELL LINEAGE; CONFERENCE PAPER; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; IMMUNOCOMPROMISED PATIENT; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MEASLES VIRUS; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OXIDATIVE STRESS; PAGET BONE DISEASE; PATHOGENESIS; PHENOTYPE; PROTEIN DEGRADATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA VIRUS INFECTION; SCANDINAVIA; SIGNAL TRANSDUCTION; WILD TYPE;

MEASLES VIRUS; MUS MUSCULUS;

EID: 77950664208     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05214.x     Document Type: Conference Paper

References (33)

1. Altman, R.D. et al. 2000. Prevalence of pelvic Paget's disease of bone in the United States. J. Bone Miner. Res. 15: 461-465.
2. Kanis, J. 1998. Pathophysiology and Treatment of Paget's Disease of Bone. Martin Dunitz. London.
3. Kurihara, N. et al. 2000. Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J. Clin. Invest. 105: 607-614.
4. Roodman, G.D. & J.J. Windle. 2005. Paget disease of bone. J. Clin. Invest. 115: 200-208.
5. Cody, J.D. et al. 1997. Genetic linkage of Paget disease of the bone to chromosome 18q. Am. J. Hum. Genet. 61: 1117-1122.
6. Hocking, L.J. et al. 2001. Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am. J. Hum. Genet. 69: 1055-1061.
7. Sparks, A.B. et al. 2001. Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma. Calcif. Tissue Int. 68: 151-155.
8. Laurin,N. et al. 2002.Recurrentmutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am. J. Hum. Genet. 70: 1582-1588.
9. Park, I. et al. 1995. Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. Proc.Natl. Acad. Sci. USA 92: 12338-12342.
10. Vadlamudi, R.K. et al. 1996. p62, a phosphotyrosineindependent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J. Biol. Chem. 271: 20235-20237.
11. Shin, J. 1998. P62 and the sequestosome, a novel mechanism for protein metabolism. Arch. Pharm. Res. 21: 629-633.
12. Ishii, T. et al. 1996. Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56lck-associated protein in response to oxidative stress. Biochem. Biophys. Res. Commun. 226: 456-460.
13. Puls, A. et al. 1997. Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. Proc. Natl. Acad. Sci. USA 94: 6191-6196.
14. Sanchez, P. et al. 1998. Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol. Cell Biol. 18: 3069-3080.
15. Geetha, T. & M.W. Wooten. 2002. Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett. 512: 19-24.
16. Sanz, L. et al. 1999. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J. 18: 3044-3053.
17. Saito, A. et al. 2008. Improvement of photoaffinity SPR imaging platform and determination of the binding site of p62/SQSTM1 to p38 MAP kinase. Chem. Asian J. 3: 1607-1612.
18. Feng, Y. &G.D. Longmore. 2005. The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinaseCzeta/ p62/TRAF6 signaling complex.Mol. Cell Biol. 25: 4010-4022.
19. Sanz, L. et al. 2000. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J. 19: 1576-1586.
20. Pankiv, S. et al. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282: 24131-24145.
21. Wooten, M.W. et al. 2001. The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor. J. Biol. Chem. 276: 7709-7712.
22. Muller, G. et al. 1995. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14: 1961-1969.
23. Laurin, N. et al. 2002. Large phenotypic variability of Paget disease of bone caused by the P392L sequestosome 1/p62mutation [abstract]. J.BoneMiner.Res. 17S1: S380.
24. Kurihara, N. et al. 2007. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J. Clin. Invest. 117: 133-142.
25. Hiruma, Y. et al. 2008. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment. Hum. Mol. Genet. 17: 3708-3719.
26. Rebel, A. et al. 1977. Is Paget's disease of bone a viral infection? Calcif. Tissue Res. 22(Suppl): 283-286.
27. Mills, B.G. et al. 1984. Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin. Orthop. Relat. Res. 303-311.
28. Gordon, M.T., A.P. Mee & P.T. Sharpe. 1994. Paramyxoviruses in Paget's disease. Semin. Arthritis Rheum. 23: 232-234.
29. Mee, A.P. et al. 1998. Detection of canine distemper virus in 100% of Paget's disease samples by in situ-reverse transcriptase-polymerase chain reaction. Bone 23: 171-175.
30. Ooi, C.G. et al. 2000.Absence ofmeasles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 27: 417-421.
31. Kurihara, N. et al. 2006. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's diseaselike bone lesions in mice. J. Bone Miner. Res. 21: 446-455.
32. Kurihara,N. et al. 2007.Measles virus nucleocapsid gene expression is required for abnormal osteoclast activity in Paget's disease of bone [abstract]. 29th Annual Meeting of American Society of Bone and Mineral. Honolulu, Hawaii. Sept. 14-19.
33. Moscat, J. et al. 2006. Cell signaling and function organized by PB1 domain interactions. Mol. Cell. 23: 631-640.